Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004728 · ClinicalTrials.gov registry record · Phase 3
Aspirin Or Warfarin To Prevent Stroke
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00004728: Clinical Trial Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00004728 is a Phase 3 study that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004728, a Phase 3 study, was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
Interventions
- DRUG Aspirin
- DRUG Warfarin
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2003-07 |
| Phase | Phase 3 |
Why NCT00004728 stopped before completion
NCT00004728 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.
NCT00004728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004728 about?
NCT00004728 is a clinical study titled "Aspirin Or Warfarin To Prevent Stroke". The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
What is the current status of trial NCT00004728?
This trial is currently terminated. It is a Phase 3 study. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00004728?
The interventions under investigation include: Aspirin (DRUG), Warfarin (DRUG).
Who is sponsoring clinical trial NCT00004728?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.